How AI Is Helping Psychiatrists Make Faster, Smarter Treatment Decisions
Clinical trials, real-world data and digital biomarkers are turning artificial intelligence into a practical ally in the fight against depression.
Why Consumers Should Care About Biomarkers — And How Technology Developers and Manufacturers Can Bridge the Gap
More precise and consumer-friendly biomarker detection technologies are coming to market at a pace that can help users gain rich insight into their health and well-being from anywhere and at any time. This is especially important when it comes to preventive healthcare.
As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
Digital Biomarkers: The Key to Delivering on the Promise of Personalized Medicine
Digital biomarkers today serve as a valuable monitoring tool, providing details about a patient’s general health and response to treatment. But, as technology continues to develop, they could fuel predictive insights about a patient’s future health outcomes and disease trajectory, as well as demonstrate measurable quality of life improvements.
Digital biomarkers: Lots of potential, but where’s the validation?
There's still a gap between potential and validation when it comes to digital biomarkers.